The new test utilizes microRNA (miRNA), a substance that is secreted from cells into the blood and regulates the movements of genes. Types of miRNA differ between cancer cells and normal cells, and they do not decompose for a certain period of time. The team is composed of researchers from the center, Toray Industries Inc. — which has the testing technology — and other institutions. They succeeded in identifying miRNA specific to 13 kinds of cancers, such as breast, lung, stomach, colorectal, esophagus, liver and pancreatic cancers, from the preserved blood of about 40,000 patients, most of whom were cancer...